Results 91 to 100 of about 202,517 (312)

Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1474-1478, April 2025.
Abstract Aims ZSF1 obese rats harbouring two mutant leptin receptor alleles (Leprcp and Leprfa) develop metabolic syndrome and heart failure with preserved ejection fraction (HFpEF), making them a widely used animal model in cardiometabolic research.
Petra Büttner, Antje Augstein, Mahmoud Abdellatif, André Lourenço, Adelino Leite‐Moreira, Inês Falcão‐Pires, Sarah Werner, Holger Thiele, Simon Sedej, Antje Schauer, Volker Adams   +10 more
wiley   +1 more source

New Prognostic Maekers in Patients After Mitral Valve Replacement: Rolo of Metalloproteinases [PDF]

, 2017
Objective: Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases involved in extra-cellular matrix remodelling, associated with both physiological and pathological processes of several human tissues and systems, such as vascular system. In
Argano V, Balistreri CR, Allegra A, Pisano C   +3 more
core   +1 more source

Mitral Annular Function in Mitral Annular Calcification and Severe Mitral Regurgitation

JACC: Advances
Longitudinal left ventricular (LV) shortening, or mitral atrioventricular plane displacement (AVPD), reflects mitral annular function.The authors sought to demonstrate the use of cardiac computed tomography (CCT) to measure mitral AVPD and assess its contribution to LV stroke volume (LVSV) in patients with mitral annular calcification (MAC), severe ...
Joseph Kassab, Joseph Hajj, Serge C. Harb, Rhonda Miyasaka, Grant Reed, Amar Krishnaswamy, Kari Feldt, Christopher U. Meduri, A. Marc Gillinov, Shinya Unai, James J. Yun, Marcus Carlsson, Samir R. Kapadia, Rishi Puri   +13 more
openaire   +3 more sources

Percutaneous mitral valve commissurotomy

, 2019
Transcatheter therapies have progressively assumed a major role in the treatment of valve heart disease. The major drivers have been population ageing, the high prevalence of valve disease in the elderly, and the consequent need of less invasive ...
Mauro Massussi, Giuseppe Tarantini, Antonio G. Bruno, Francesco Saia   +3 more
core   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

The correlation between the coaptation height of mitral valve and mitral regurgitation after mitral valve repair

Journal of Cardiothoracic Surgery, 2017
Background To investigate the association between the coaptation height of mitral valve and mitral regurgitation after mitral valve repair. Methods From Sep 2014 to Jun 2015, 20 patients underwent mitral valve valvuloplasty for mitral regurgitation were ...
Dan Wei, Jie Han, Haibo Zhang, Yan Li, Chunlei Xu, Xu Meng   +5 more
doaj   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Recent advances in understanding and managing mitral valve disease [version 1; peer review: 2 approved]

F1000Research, 2019
Interest in the mitral valve has increased over the past few years with the development of new technologies that allow intervention in patients previously deemed too ill for treatment.
Wendy Tsang
doaj   +1 more source

Mitral Valve Disease and Mitral Valvotomy [PDF]

BMJ, 1955
J F, GOODWIN, J D, HUNTER, W P, CLELAND, L G, DAVIES, R E, STEINER   +4 more
openaire   +2 more sources